Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations (OPS II)
A Randomized, Double-blind, Placebo Controlled Trial of Testosterone Undecanoate for Optimizing Physical and Cognitive Performance During Military Operations (OPS II)
Sponsor: Pennington Biomedical Research Center
A PHASE4 clinical study on Caloric Restriction and Exercise, this trial is completed. The trial is conducted by Pennington Biomedical Research Center and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Nov 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Nov 2022 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Nov 2019 — Oct 2020 [monthly]
Recruiting PHASE4
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pennington Biomedical Research Center
- United States Army Research Institute of Environmental Medicine
- United States Department of Defense
- University of Arkansas
For direct contact, visit the study record on ClinicalTrials.gov .